Guangzhou Runhong Pharmaceutical Technology Co., Ltd. was established on December 16, 2004 with a registered capital of 13.899566 million. It is located in Yongxing Light Industrial Park, Yonghe Economic Zone, Development Zone, with a construction area of more than 5000 square meters. It is a company specializing in R&D, production and sales. A high-tech and standardized national high-tech enterprise of trauma therapy biomedical materials (new materials in the national high-tech field-biomedical materials).
The company has built a factory in line with the management standards of medical device manufacturing enterprises, with a 100,000-level purification production workshop and production line, 10,000 level microbiology laboratory, and through ISO13485 certification, through the "medical device manufacturing enterprise quality System assessment". Currently, the main products are Medical functional dressing (Spray type, foam type, Negative Pressure Wound Therapy, Chitosan Wound Dressing, Alginate Wound Dressing, all belong to new material - biomedical material - new dressing and hemostatic material preparation technology. The market is all over the country.
In addition, the company has also developed Medical ultrasonic couplant, Medicative scar paster, disinfectant, nasal care, skin health care and other products, which have been widely recognized by the industry customers and consumers.
The company has built a factory building that meets the management standards of medical device manufacturers, has a 100,000-level purification production workshop, a production line, and a 10,000-level microbiological laboratory. It has passed ISO13485 certification and passed the "Quality System Assessment for Medical Device Manufacturers". At present, the company's main products are chitosan antibacterial film-forming sprays, medical functional dressings, disposable negative pressure drainage wound care materials, chitosan dressings, and alginate dressings, all of which are new materials-biomedical materials-new dressings And hemostatic material preparation technology, the market spreads all over the country. In 2014,Daan Gene becoming a shareholder of our company, we have introduced excellent management experience, strong scientific research capabilities and a huge sales platform to further promote the development of Runhong. In June 2017, our company has completed the share reform and submitted materials to the national SME share transfer system, and successfully listed in September.
In recent years, the company adhere to the market demand as the guidance, continue to increase research and innovation efforts, research and development ofnegative press exported to the United States, Poland, Chile, Brazil, Mexico, United Arab Emirates, Indonesia, Philippines, Vietnam, India and other countries, favored by domestic and foreign markets.
Runhong's technology research and development are managed in strict accordance with intellectual property management regulations, putting technological innovation and intellectual property protection in the first place, and the 2017 intellectual property management system certification certificate. At present, the company has applied for more than 293 patents, has 140 authorized patents; 220 trademark registrations, 162 certificates obtained; 5 copyright registrations; 21 Guangdong high-tech products. The company actively cooperates with universities and scientific research institutes, and has reached cooperation with Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Sun Yat-sen University, Jinan University, and South China University of Technology. At the same time, the company attaches great importance to the transformation of scientific and technological achievements. Currently, it has obtained 31 medical device certificates, including 7 for category three, 14 for category two, and 10 for category one. Our company continues to accumulate experience in clinical medical device product development and registration and approval, and the achievement conversion rate is relatively high. This year, it was rated as a major scientific and technological achievement transformation base in Guangdong Province, and highly affirmed our research investment, industry-university-research cooperation, and product development.
Guangzhou Runhong Pharmaceutical Technology Co., Ltd. has always adhered to the strategic direction of promoting development through innovation, increasing investment, accelerating construction, and boldly exploring, and continuously improving the company's independent innovation capabilities. In November 2017, we won the China Patent Excellence Award; as the only participating unit, our company participated in the preparation of the chitosan dressing landmark led by the Guangdong Medical Device Quality Supervision and Inspection Institute, and it was announced in November 2017; it was selected in 2017 The supervisory member unit of the Guangdong Medical Device Industry Association, was identified as the industrialization base of new biomedical materials scientific and technological achievements, the Guangdong Engineering Technology Research Center for Biomedical Materials and Rehabilitation Nursing Products, and the Guangdong Natural Products and New Drug R&D Engineering Technology Research Center, established The Guangdong Provincial High-end Functional Medical Dressing Industry Technology Innovation Alliance.
To build a benchmark enterprise in the field of trauma therapy, and strive to become an ever-lasting innovative company in the health industry.
Caring for patients and giving back to society
People-oriented, create value
Stability, innovation, excellence, and win-win
Look to the future
In recent years, the company has continuously promoted the research of surgical trauma products, and at the same time expands the breadth of wound treatment peripheral products to meet clinical needs, and requires itself at an annual growth rate of 30%, striving to become a benchmark enterprise for medical trauma products. In the future, we will increase investment in innovation, attract more outstanding talents, continuously inject fresh blood into the company, and constantly bring forth new ideas, so as to achieve the goal of creating a technologically innovative enterprise. At the same time, strengthen team building, maintain the spirit of striving for excellence and indomitable enterprising innovation, and strive to push the company's development strategy to an updated stage, and strive to create a new situation.
Guangzhou Runhong Pharmaceutical Technology Co., Ltd. insists on taking the road of high-tech industry development, taking technology as life and technological innovation as the core competitiveness of enterprises, and strives to cultivate its own scientific research and technology development team, cultivate high-tech projects with market prospects, and establish A number of investment projects with high technological content and good economic benefits have effectively promoted the revitalization and development of Runhong Pharmaceutical. Fully absorb corporate and social forces, enhance corporate technological innovation capabilities, and increase product added value and competitiveness.
Runhong Pharmaceutical has always adhered to the strategic direction of promoting development through innovation, increasing investment, accelerating construction, boldly pioneering, and continuously improving the independent innovation capabilities of the company. In 2012, the company was recognized as a "private technology enterprise in Guangdong Province" by Guangdong Province. It was recognized as a "private technology enterprise in Guangdong Province" by Guangzhou City, was named a "High-tech Enterprise of Guangdong Province" and "Member Unit of the Standards Committee" in 2014, and was recognized as a "Research Base for Trauma Repair and Treatment" in 2015.
The R & D center has 10 full-time R & D personnel, 3 with master's degree or above, 7 with bachelor's degree or above, and 2 with intermediate or above title. In recent years, it has won 5 Chinese patent Excellence awards and 1 national science and technology project. 5 provincial science and technology projects; 5 municipal science and technology projects; 1 patent industrialization project approved by Guangzhou Intellectual Property Office; It has 2 provincial engineering and technology research centers.
New products independently developed by our company include: Medical Negative Pressure Wound Therapy Device,disposable negative pressure drainage wound care materials, chitosan antibacterial sprays, chitosan dressings, alginate dressings, sterile dressings, surgical gauze, sterile medical ultrasonic coupling agents , Medical ultrasonic coupling agent for cavity, scar patch, saline nasal cavity care device, etc. At the same time, Runhong adheres to the principle of combining production, teaching and research, and complementing each other's unique technological advantages, taking the enterprise as the main body, market-oriented, and relying on the resources of scientific research institutes and universities to enhance the company's R&D capabilities;
Developed a series of industry-university-research cooperation projects with Jinan University, Wuhan University, Sun Yat-sen University, Zhongshan Affiliated One, South China Agricultural University, and Institute of Microbiology, Guangdong Branch of Chinese Academy of Sciences.